Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T13:25:54.119Z.
Calculation as of: 2026-10-06T13:25:54.119Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 412370d08cb3fb7a3c2e4d636897a8ea9259835d42853a062d33098765049a4f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2016-03-31.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$368.91M
EV/EBITDA Ratio
N/A
TTM Avg
40.38x
3Y Avg
40.38x
5Y Avg
40.38x
Market Cap
$366.39M
EV/EBITDA Ratio
N/A
TTM Avg
37.95x
3Y Avg
29.61x
5Y Avg
22.14x
Market Cap
$384.23M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$348.59M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canopy Growth Corporation (CGC) | $373.40M | N/A | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $368.91M | N/A | 40.38x | 40.38x | 40.38x |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $366.39M | N/A | 37.95x | 29.61x | 22.14x |
| Agenus Inc. (AGEN)vs › | $363.54M | 9.42x | 20.16x | 20.16x | 12.62x |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $384.23M | N/A | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $348.85M | 5.36x | 4.73x | 7.57x | 7.31x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $348.59M | N/A | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $345.48M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2016-03-31 | 665.65x |
| 2016-03-30 | 663.97x |
| 2016-03-29 | 649.23x |
| 2016-03-28 | 657.61x |
| 2016-03-24 | 655.26x |
| 2016-03-23 | 642.20x |
| 2016-03-22 | 688.43x |
| 2016-03-21 | 688.43x |
| 2016-03-18 | 697.14x |
| 2016-03-17 | 695.80x |
| 2016-03-16 | 661.29x |
| 2016-03-15 | 667.32x |
| 2016-03-14 | 689.10x |
| 2016-03-11 | 708.20x |
| 2016-03-10 | 717.24x |
| 2016-03-09 | 727.63x |
| 2016-03-08 | 720.59x |
| 2016-03-07 | 729.64x |
| 2016-03-04 | 737.68x |
| 2016-03-03 | 727.63x |
| 2016-03-02 | 741.70x |
| 2016-03-01 | 744.72x |
| 2016-02-29 | 726.96x |
| 2016-02-26 | 716.24x |
| 2016-02-25 | 709.87x |
| 2016-02-24 | 716.24x |
| 2016-02-23 | 754.10x |
| 2016-02-22 | 698.82x |
| 2016-02-19 | 671.01x |
| 2016-02-18 | 669.33x |
| 2016-02-17 | 675.03x |
| 2016-02-16 | 655.93x |
| 2016-02-12 | 649.57x |
| 2016-02-11 | 619.08x |
| 2016-02-10 | 623.10x |
| 2016-02-09 | 631.48x |
| 2016-02-08 | 610.03x |
| 2016-02-05 | 631.14x |
| 2016-02-04 | 643.87x |
| 2016-02-03 | 639.18x |
| 2016-02-02 | 622.43x |
| 2016-02-01 | 646.55x |
| 2016-01-29 | 637.51x |
| 2016-01-28 | 631.48x |
| 2016-01-27 | 636.17x |
| 2016-01-26 | 632.82x |
| 2016-01-25 | 631.14x |
| 2016-01-22 | 639.18x |
| 2016-01-21 | 629.13x |
| 2016-01-20 | 612.38x |
| 2016-01-19 | 616.06x |
| 2016-01-15 | 620.75x |
| 2016-01-14 | 645.88x |
| 2016-01-13 | 649.90x |
| 2016-01-12 | 666.32x |
| 2016-01-11 | 668.66x |
| 2016-01-08 | 656.94x |
| 2016-01-07 | 610.37x |
| 2016-01-06 | 667.66x |
| 2016-01-05 | 693.46x |
| 2016-01-04 | 696.14x |
| 2015-12-31 | 793.73x |
| 2015-12-30 | 785.24x |
| 2015-12-29 | 783.39x |
| 2015-12-28 | 774.89x |
| 2015-12-24 | 774.89x |
| 2015-12-23 | 762.71x |
| 2015-12-22 | 743.50x |
| 2015-12-21 | 752.00x |
| 2015-12-18 | 742.39x |
| 2015-12-17 | 737.96x |
| 2015-12-16 | 774.89x |
| 2015-12-15 | 752.37x |
| 2015-12-14 | 741.66x |
| 2015-12-11 | 735.38x |
| 2015-12-10 | 759.38x |
| 2015-12-09 | 760.12x |
| 2015-12-08 | 761.60x |
| 2015-12-07 | 799.64x |
| 2015-12-04 | 784.50x |
| 2015-12-03 | 761.23x |
| 2015-12-02 | 766.77x |
| 2015-12-01 | 763.45x |
| 2015-11-30 | 774.89x |
| 2015-11-27 | 757.54x |
| 2015-11-25 | 678.50x |
| 2015-11-24 | 672.59x |
| 2015-11-23 | 658.19x |
| 2015-11-20 | 660.41x |
| 2015-11-19 | 661.52x |
| 2015-11-18 | 699.19x |
| 2015-11-17 | 730.58x |
| 2015-11-16 | 651.54x |
| 2015-11-13 | 614.61x |
| 2015-11-12 | 606.86x |
| 2015-11-11 | 679.98x |
| 2015-11-10 | 734.27x |
| 2015-11-09 | 751.63x |
| 2015-11-06 | 734.27x |
| 2015-11-05 | 884.21x |
| 2015-11-04 | 952.17x |
| 2015-11-03 | 885.69x |
| 2015-11-02 | 824.38x |
| 2015-10-30 | 763.08x |
| 2015-10-29 | 701.77x |
| 2015-10-28 | 719.50x |
| 2015-10-27 | 713.22x |
| 2015-10-26 | 655.61x |
| 2015-10-23 | 627.17x |
| 2015-10-22 | 685.52x |
| 2015-10-21 | 608.70x |
| 2015-10-20 | 572.51x |
| 2015-10-19 | 618.67x |
| 2015-10-16 | 578.05x |
| 2015-10-15 | 571.03x |
| 2015-10-14 | 537.79x |
| 2015-10-13 | 501.60x |
| 2015-10-09 | 493.85x |
| 2015-10-07 | 481.29x |
| 2015-10-06 | 502.71x |
| 2015-10-05 | 455.44x |
| 2015-10-02 | 449.53x |
| 2015-10-01 | 452.11x |
